Is the price fair?
What HRMY's price assumes
Harmony Biosciences Holdings, Inc. trades at 15.9× earnings against 32.4× for the median Biotechnology name, cheaper than its own group.
15.9
Trailing P/E · Biotechnology median 32.4 · cheaper than the typical name in its group
- Price / sales
- 1.83
Price / sales · as of 2026-Q1
- Price / book
- 1.81
Price / book · as of 2026-Q1
- EV / sales
- 1.35
EV / sales
Details›
- Price / book2026-Q1
- 1.81
- EV / EBIT2026-Q1
- 6.42
- EV / sales2026-Q1
- 1.35
- Healthcare median P/E362 names
- 31.5
- Biotechnology median P/E158 names
- 32.4
- Market capitalisation
- $1.93B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $33.20 |
| Its own P/E history, median | $37.15 |
| Its own P/E history, upper quartile | $84.31 |
| 52-week range | $25.90 – $40.51 |
| Today | $39.64 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.